Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21037/tau.2017.03.57 http://scihub22266oqcxt.onion/10.21037/tau.2017.03.57 C5422692!5422692!28540239     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 261.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 261.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transl+Androl+Urol 2017 ; 6 (2): 295-304 Nephropedia Template TP {{tp|p=28540239|t=2017. The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia |pdf=|usr=}}{{28540239}} gab.com Text The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia JO: Transl Androl Urol http://www.kidney.de/pget.php?&tw=1&pmid=28540239 #FOAvip Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS). Classes of medications include ?1-adrenoceptor blockers, 5?-reductase inhibitors, and phosphodiesterase 5 inhibitors. Today, ?1-adrenoceptor blockers and 5?-reductase inhibitors are often combined to give a synergistic effect. A review of the current literature identified several adverse sexual side effects, including erectile dysfunction (ED), decreased libido, orgasmic disorders, and ejaculatory disorders. We believe it is important to know the extent of these side effects, as the clinician and patient will need to decide the cost of improved voiding symptoms. The chief adverse effect is ejaculatory disorders, including the absence of ejaculation. Clinical consideration for BPH should include the elements of male sexual function, patients? age, and the characteristics and comprehensive effects of each group of drugs. Methodological bias in clinical studies, such as the subjective evaluation of the sexual side effect, makes it difficult to determine the ideal drug for treatment. Twit Text FOAVip The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia ????Transl Androl Urol http://www.kidney.de/pget.php?&tw=1&pmid=28540239 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28540239 #FOAvip English Wikipedia <ref>{{Cite pmid|28540239}}</ref> The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia #MMPMID28540239 Gandhi J; Weissbart SJ; Smith NL; Kaplan SA; Dagur G; Zumbo A; Joshi G; Khan SA Transl Androl Urol 2017[Apr]; 6 (2): 295-304 PMID28540239show ga Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS). Classes of medications include ?1-adrenoceptor blockers, 5?-reductase inhibitors, and phosphodiesterase 5 inhibitors. Today, ?1-adrenoceptor blockers and 5?-reductase inhibitors are often combined to give a synergistic effect. A review of the current literature identified several adverse sexual side effects, including erectile dysfunction (ED), decreased libido, orgasmic disorders, and ejaculatory disorders. We believe it is important to know the extent of these side effects, as the clinician and patient will need to decide the cost of improved voiding symptoms. The chief adverse effect is ejaculatory disorders, including the absence of ejaculation. Clinical consideration for BPH should include the elements of male sexual function, patients? age, and the characteristics and comprehensive effects of each group of drugs. Methodological bias in clinical studies, such as the subjective evaluation of the sexual side effect, makes it difficult to determine the ideal drug for treatment. äThe impact and management of sexual dysfunction secondary to pharmacol(epmc).pdf DeepDyve Pubget Overpricing